Baird Mid Cap Growth Institutional holds a quantitatively derived Negative Morningstar Medalist Rating. The rating indicates the model sees limited potential for the strategy to outperform peers on a risk-adjusted basis over a full market cycle.
Baird Mid Cap Growth Fund Institutional Class BMDIX
- NAV / 1-Day Return $19.85 / +0.30 %
- Fund Size $417.6M
- Adjusted Expense Ratio 0.850%
- Net Expense Ratio 0.820%
- Fee Level: Distribution Average
- Share Class Type Institutional
- Morningstar Category Mid-Cap Growth
- Equity Style Box (Funds) Mid Growth
- Minimum Initial Investment $10,000
- Investment Status Open
- TTM Yield 0.00%
- Turnover Ratio 63%
Morningstar’s Analysis BMDIX
Will BMDIX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 27.6
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Illumina Inc | 3.39 | 15M | Healthcare |
Victoria's Secret & Co | 3.21 | 14M | Consumer Cyclical |
Fastenal Co | 3.08 | 14M | Industrials |
Twilio Inc Class A | 2.97 | 13M | Technology |
Repligen Corp | 2.79 | 12M | Healthcare |
Datadog Inc Class A | 2.63 | 12M | Technology |
Veeva Systems Inc Class A | 2.49 | 11M | Healthcare |
MSCI Inc | 2.42 | 11M | Financial Services |
West Pharmaceutical Services Inc | 2.37 | 11M | Healthcare |
DexCom Inc | 2.28 | 10M | Healthcare |